Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results

Go back to Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results
(NASDAQ: AVIR) Delayed: 5.68 -0.15 (2.57%)
Previous Close $5.83    52 Week High $2.00 
Open $5.80    52 Week Low $1.15 
Day High $5.85    P/E N/A 
Day Low $5.64    EPS $0.00 
Volume 216,581